JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108253

重组Anti-beta Amyloid 1-38抗体[EPR1878(2)]

Anti-beta Amyloid 1-38 antibody [EPR1878(2)]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal Amyloid-beta precursor protein antibody. Suitable for sELISA, WB and reacts with Synthetic peptide, Recombinant fragment samples. Cited in 1 publication.

查看别名

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

2 Images
Sandwich ELISA - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] (AB108253)
  • sELISA

Lab

Sandwich ELISA - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] (AB108253)

ELISA of beta Amyloid 1-38 peptide at 2μg/mL. Detected with ab108253 at 0~500 pg/mL. Peroxidase Streptavidin SA-HRP at 1/20000 was used as a secondary antibody.

Washing buffer : 1X PBST
Blocking buffer : 1% BSA/PBS

Western blot - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] (AB108253)
  • WB

Unknown

Western blot - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] (AB108253)

All lanes:

Western blot - Anti-beta Amyloid 1-38 antibody [EPR1878(2)] (ab108253) at 1/1000 dilution

Lane 1:

Abeta38 protein at 10 µg

Lane 2:

Abeta40 protein at 10 µg

Lane 3:

Abeta42 protein at 10 µg

Predicted band size: 86 kDa

false

不同偶联物与剂型 (2)

  • Carrier free

    Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free (Detector)

  • Carrier free

    Anti-beta Amyloid 1-38 antibody [EPR1878(2)] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR1878(2)

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB, sELISA

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特异性

ab108253 is specific to the cleaved peptide Abeta38.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "sELISA" : {"fullname" : "Sandwich ELISA", "shortname":"sELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "sELISA-species-checked": "predicted", "sELISA-species-dilution-info": "", "sELISA-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Recombinant fragment": { "sELISA-species-checked": "notRecommended", "sELISA-species-dilution-info": "", "sELISA-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>" }, "Synthetic peptide": { "sELISA-species-checked": "testedAndGuaranteed", "sELISA-species-dilution-info": "1 µg/mL", "sELISA-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
运输条件
Conditional Ambient
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
储存信息
Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

Beta Amyloid 1-38 also known as Aβ1-38 is a peptide that originates from the amyloid precursor protein (APP) through proteolytic processing. This peptide has a mass of approximately 4.17 kDa. Aβ1-38 is expressed in the brain and other tissues and it plays a role in the complex network of amyloidogenic processing. Its generation results from the sequential cleavage of APP by beta-secretase and gamma-secretase enzymes where it is one of the shorter forms of amyloid-beta peptides produced.
Biological function summary

Beta amyloid 1-38 participates in amyloid plaque formation which is significant in neurodegenerative processes. This peptide is part of a heterogenous group of amyloid-beta peptides which includes other forms like beta amyloid 1-40 and beta amyloid 1-42. Aβ1-38 contributes to the complex accumulation and aggregation of amyloid fibrils that have implications in synaptic functions and neuronal health. Its interactions influence cell signaling pathways and processes involved in cellular stress responses.

Pathways

Beta amyloid 1-38 plays a role in the amyloidogenesis pathway. This pathway impacts the regulation of synaptic activity and neural communication. The peptide is integrated into pathways connected with mitochondrial function and oxidative stress influencing how neurons react to metabolic demands. Proteins related to this pathway include presenilin which is a component of the gamma-secretase complex responsible for APP processing and tau protein which is involved in microtubule stability within cells.

Beta amyloid 1-38 is important in the pathology of Alzheimer's disease. The peptide's accumulation contributes to the formation of amyloid plaques a hallmark of the disease. Another disorder linked to beta amyloid peptide aggregates is cerebral amyloid angiopathy where the deposition in cerebral vessels can lead to vascular damage. Aβ1-38's relationship with proteins such as tau which forms neurofibrillary tangles in Alzheimer's highlights shared pathogenic mechanisms in these disorders.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed : 25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed : 17062754, PubMed : 23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.. Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.. Amyloid-beta protein 42. More effective reductant than amyloid-beta protein 40. May activate mononuclear phagocytes in the brain and elicit inflammatory responses.. Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.. The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
See full target information APP

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 9:12574 PubMed31467395

2019

Fundamental differences in patterns of retinal ageing between primates and mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jaimie Hoh Kam,Tobias W Weinrich,Harpreet Shinhmar,Michael B Powner,Nicholas W Roberts,Asmaa Aboelnour,Glen Jeffery
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com